Login / Signup

Thymosin beta-4 improves endothelial function and reparative potency of diabetic endothelial cells differentiated from patient induced pluripotent stem cells.

Liping SuXiaocen KongSzejie LooYu GaoBingli LiuXiaofei SuRinkoo DalanJianhua MaLei Ye
Published in: Stem cell research & therapy (2022)
Tb-4 improves endothelial dysfunction through enhancing hiPSC-EC viability, reducing senescence and endothelin-1 production, and improves angiogenic potency in diabetes.
Keyphrases
  • endothelial cells
  • induced pluripotent stem cells
  • type diabetes
  • cardiovascular disease
  • mycobacterium tuberculosis
  • dna damage
  • case report
  • metabolic syndrome
  • oxidative stress
  • wound healing